Medical Market Report

Global Bone Marrow Transplant Market By Type (Autologous Hematopoietic Stem Cell Transplantation, Syngeneic Hematopoietic Stem Cell Transplantation, and Allo-HSCT), By Application (Acute Leukemia, and Chronic Leukemia), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 138130
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    Global Bone Marrow Transplant Market is estimated to be valued US$ XX.X million in 2019. The report on Bone Marrow Transplant Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global bone marrow transplant market is segmented on the basis of Type, Application, and geography.

    Europe market was valued at US$ XX.X million in 2018 and is projected to reach US$ XX.X million in 2029, and register a CAGR of X.X% during the forecast period, according to a new Market.us (Prudour Research) study.

    Bone Marrow Transplant Market Scope:

    By type, the market is segmented into Autologous Hematopoietic Stem Cell Transplantation, Syngeneic Hematopoietic Stem Cell Transplantation, and Allo-HSCT. By Application, the market is divided into Acute Leukemia, and Chronic Leukemia.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include AllCells (USA), Lonza (Switzerland), Merck (USA), Sanofi (France), Translational Biosciences (USA), Athersys (USA), Beike Biotechnology (China), BioTime (USA), Bluebird Bio (USA), Caladrius (USA), Cellular Biomedicine Group (USA), Cesca Therapeutics (USA), TiGenix (Belgium), CHA Biotech (Korea), Chugai Pharmaceutical (UK), CORESTEM (Korea), Gamida Cell (USA), Histocell (Spain), and Hemostemix (Canada).

    Key Market Segments

    Type

    Autologous Hematopoietic Stem Cell Transplantation

    Syngeneic Hematopoietic Stem Cell Transplantation

    Allo-HSCT

    Application

    Acute Leukemia

    Chronic Leukemia

    Key Market Players included in the report:

    AllCells (USA)

    Lonza (Switzerland)

    Merck (USA)

    Sanofi (France)

    Translational Biosciences (USA)

    Athersys (USA)

    Beike Biotechnology (China)

    BioTime (USA)

    Bluebird Bio (USA)

    Caladrius (USA)

    Cellular Biomedicine Group (USA)

    Cesca Therapeutics (USA)

    TiGenix (Belgium)

    CHA Biotech (Korea)

    Chugai Pharmaceutical (UK)

    CORESTEM (Korea)

    Gamida Cell (USA)

    Histocell (Spain)

    Hemostemix (Canada)

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Bone Marrow Transplant Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Bone Marrow Transplant Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Bone Marrow Transplant Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Bone Marrow Transplant Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Bone Marrow Transplant Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Bone Marrow Transplant Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Bone Marrow Transplant sub-markets, depending on key regions (various vital states).
    To analyze Bone Marrow Transplant Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Bone Marrow Transplant Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
    Primary worldwide Bone Marrow Transplant Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Bone Marrow Transplant Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players3. Global Bone Marrow Transplant Market Overview
    

    3.1. Bone Marrow Transplant Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges  3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy4. Global Bone Marrow Transplant Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Bone Marrow Transplant Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Autologous Hematopoietic Stem Cell Transplantation
    

      4.4. Syngeneic Hematopoietic Stem Cell Transplantation
    

      4.5. Allo-HSCT5. Global Bone Marrow Transplant Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Bone Marrow Transplant Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Acute Leukemia
    

      5.4. Chronic Leukemia6. Global Bone Marrow Transplant Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Bone Marrow Transplant Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Bone Marrow Transplant Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Bone Marrow Transplant Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Bone Marrow Transplant Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Bone Marrow Transplant Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    
7. Global Bone Marrow Transplant Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. AllCells (USA)
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments  7.4. Lonza (Switzerland)
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments  7.5. Merck (USA)
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments  7.6. Sanofi (France)
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments  7.7. Translational Biosciences (USA)
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments  7.8. Athersys (USA)
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments  7.9. Beike Biotechnology (China)
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments  7.10. BioTime (USA)
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments  7.11. Bluebird Bio (USA)
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments  7.12. Caladrius (USA)
    

        7.12.1. Company Overview
    
    7.12.2. Financial Highlights
    
    7.12.3. Product Portfolio
    
    7.12.4. SWOT Analysis
    
    7.12.5. Key Strategies and Developments  7.13. Cellular Biomedicine Group (USA)
    

        7.13.1. Company Overview
    
    7.13.2. Financial Highlights
    
    7.13.3. Product Portfolio
    
    7.13.4. SWOT Analysis
    
    7.13.5. Key Strategies and Developments  7.14. Cesca Therapeutics (USA)
    

        7.14.1. Company Overview
    
    7.14.2. Financial Highlights
    
    7.14.3. Product Portfolio
    
    7.14.4. SWOT Analysis
    
    7.14.5. Key Strategies and Developments  7.15. TiGenix (Belgium)
    

        7.15.1. Company Overview
    
    7.15.2. Financial Highlights
    
    7.15.3. Product Portfolio
    
    7.15.4. SWOT Analysis
    
    7.15.5. Key Strategies and Developments  7.16. CHA Biotech (Korea)
    

        7.16.1. Company Overview
    
    7.16.2. Financial Highlights
    
    7.16.3. Product Portfolio
    
    7.16.4. SWOT Analysis
    
    7.16.5. Key Strategies and Developments  7.17. Chugai Pharmaceutical (UK)
    

        7.17.1. Company Overview
    
    7.17.2. Financial Highlights
    
    7.17.3. Product Portfolio
    
    7.17.4. SWOT Analysis
    
    7.17.5. Key Strategies and Developments  7.18. CORESTEM (Korea)
    

        7.18.1. Company Overview
    
    7.18.2. Financial Highlights
    
    7.18.3. Product Portfolio
    
    7.18.4. SWOT Analysis
    
    7.18.5. Key Strategies and Developments  7.19. Gamida Cell (USA)
    

        7.19.1. Company Overview
    
    7.19.2. Financial Highlights
    
    7.19.3. Product Portfolio
    
    7.19.4. SWOT Analysis
    
    7.19.5. Key Strategies and Developments  7.20. Histocell (Spain)
    

        7.20.1. Company Overview
    
    7.20.2. Financial Highlights
    
    7.20.3. Product Portfolio
    
    7.20.4. SWOT Analysis
    
    7.20.5. Key Strategies and Developments  7.21. Hemostemix (Canada)
    

        7.21.1. Company Overview
    
    7.21.2. Financial Highlights
    
    7.21.3. Product Portfolio
    
    7.21.4. SWOT Analysis
    
    7.21.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.